Financhill
Back

The Descartes Systems Group Vs. Kymera Therapeutics Industry Stock Comparison

Buy
56

DSGX
The Descartes Systems Group

Last Price:
$104.27
Seasonality Move:
5.27%
Buy
70

KYMR
Kymera Therapeutics

Last Price:
$44.81
Seasonality Move:
5.78%
Buy
56
The Descartes Systems Group (DSGX) is a Buy

Is The Descartes Systems Group a Buy, Sell or Hold?

  • The current The Descartes Systems Group [DSGX] share price is $104.38. The Score for DSGX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • DSGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
70
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $44.79. The Score for KYMR is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

DSGX Stock Price Chart

What is The Descartes Systems Group's stock price today?

  • The The Descartes Systems Group share price today is $104.38
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DSGX is experiencing buying pressure, which is a positive indicator for future bullish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $44.79
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight buying pressure.

DSGX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.97 Sell
Relative Strength Index (14 RSI): 52.11 Buy
Chaikin Money Flow: 363682 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (97.76 - 109.46) Buy
Bollinger Bands (100): (99.55 - 112.79) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.92 Buy
Relative Strength Index (14 RSI): 58.43 Buy
Chaikin Money Flow: 47554 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (40.09 - 49.29) Buy
Bollinger Bands (100): (27.22 - 41.78) Buy

DSGX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 102.15 Buy
20-day SMA: 100.79 Buy
50-day SMA: 106.78 Sell
200-day SMA: 108.6 Sell
8-day EMA: 102.14 Buy
20-day EMA: 102.8 Buy
50-day EMA: 99.01 Buy
200-day EMA: 54.45 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.11 Sell
20-day SMA: 46.32 Sell
50-day SMA: 38 Buy
200-day SMA: 39.54 Buy
8-day EMA: 44.94 Sell
20-day EMA: 44.02 Buy
50-day EMA: 39.8 Buy
200-day EMA: 37.62 Buy

The Descartes Systems Group Earnings Growth & DSGX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.03 per share, an increase this year of $0.62 per share, and an increase next year of $0.23 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.17 per share, a decrease this year of $0.67 per share, and a decrease next year of $0.49 per share.

The Descartes Systems Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):